HF
IBB icon

Hoxton Financial’s iShares Biotechnology ETF IBB Stock Holding History

Hoxton Financial’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$7K Hold
84
– – ﹤0.01% 267
2015
Q4 		$9K Buy
+84
New +$9.12K ﹤0.01% 239

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Hoxton Financial's IBB Position: Q1 2016 in Review

Hoxton Financial held its iShares Biotechnology ETF (IBB) position steady in Q1 2016 at 84 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Hoxton Financial first reported a position in IBB in Q4 2015 and has held it in 2 quarters since. The position peaked at $9K in Q4 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

  • Hoxton Financial held 84 shares of iShares Biotechnology ETF worth $7K as of Q1 2016.
  • Hoxton Financial left its iShares Biotechnology ETF share count unchanged in Q1 2016.
  • iShares Biotechnology ETF made up ﹤0.01% of Hoxton Financial's portfolio in Q1 2016, its #267 holding.
  • Hoxton Financial first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 2 quarters since.
  • Hoxton Financial's iShares Biotechnology ETF position peaked at $9K in Q4 2015.
  • 415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.